Department of Hepatopancreatobiliary Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Department of Neurology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Cancer Med. 2019 Sep;8(12):5638-5650. doi: 10.1002/cam4.2489. Epub 2019 Aug 6.
MicroRNAs (miRNAs) are noncoding single-stranded RNAs, approximately 20-24 nucleotides in length, known as powerful posttranscriptional regulators. miRNAs play important regulatory roles in cellular processes by changing messenger RNA expression and are widely involved in human diseases, including tumors. It has been reported in the literature that miRNAs have a precise role in cell proliferation, programmed cell death, differentiation, and expression of coding genes. MicroRNA-124 (miR-124) has reduced exparession in various human neoplasms and is believed to be related to the occurrence, development, and prognosis of malignant tumors. In our review, we focus on the specific molecular functions of miR-124 and the downstream gene targets in major cancers, which provide preclinical evidence for the treatment of human cancer. Although some obstacles exist, miR-124 is still attracting intensive research focus as a promising and effective anticancer weapon.
MicroRNAs (miRNAs) 是大约 20-24 个核苷酸长的非编码单链 RNA,被称为强大的转录后调控因子。miRNAs 通过改变信使 RNA 的表达,在细胞过程中发挥重要的调节作用,广泛涉及人类疾病,包括肿瘤。文献报道,miRNAs 在细胞增殖、程序性细胞死亡、分化和编码基因表达中具有精确的作用。MicroRNA-124 (miR-124) 在各种人类肿瘤中的表达降低,被认为与恶性肿瘤的发生、发展和预后有关。在我们的综述中,我们重点关注 miR-124 的特定分子功能及其在主要癌症中的下游基因靶点,为人类癌症的治疗提供了临床前证据。尽管存在一些障碍,但 miR-124 作为一种有前途和有效的抗癌武器,仍然吸引着密集的研究关注。